Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells

Figure 6

Evaluation of secondary analysis in PC3-TR cells. (a) Single agent mitoxantrone, (b) single agent mithramycin, (c) combination treatment with mitoxantrone and 10 ng/mL TRAIL and (d) combination treatment with mithramycin and 10 ng/mL TRAIL. Analysis results performed using the MTT assay are shown as "dark grey diamonds" and analysis results performed using the live/dead stain are shown as "light grey squares". Data are presented on a logarithmic scale.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us